This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Nicole M. DeYampert; Lisa A. Beck, MD

Arch Dermatol. 1997;133(12):1584.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

REPORT OF A CASE

The patient described in the preceding quiz was referred to our Allergy Division in December 1995 for consideration of treatment with corticosteroid-sparing agents for her Wells syndrome. Her skin disease required frequent courses of systemic corticosteroids (dosage of prednisone therapy, 20-60 mg/d) since January 1995; as a consequence, she had gained more than 22 kg and experienced severe mood swings. Since her hospitalizations in June 1995, she had had flares of her skin disease, several of which produced profound swelling of her lower extremities, which made ambulation difficult. A review of her medical records documented at least 1 elevated total eosinophil count (1.5 x10⁹/L) each month since May 1995. Her highest eosinophil count (10x10⁹/L) occurred in October 1995, after rapid tapering of her steroid therapy. She stopped taking prednisone in November 1995, three weeks before she presented to us and, since then, . . . [Full Text PDF of this Article]

Author Affiliations
The Johns Hopkins University School of Medicine at The Johns Hopkins Asthma and Allergy Center, Baltimore, Md

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?